Consultant Hepatologist and Honorary Senior Lecturer at the Translational Gastroenterology and Liver Unit at the John Radcliffe Hospital and Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom. Clinical Lead for the Immune-Mediated Liver Disease service, including academic led and industry-sponsored clinical trials in autoimmune and cholestatic liver diseases. She has National and International Leadership and Steering Committee positions, broadly covering IgG4-related disease, primary sclerosing cholangitis, primary biliary cholangitis and autoimmune hepatitis. She is the Lead for the Senior Clinical Fellowship programme and has a mentorship role in the academic hepatology pathway.
Translational research focuses on immune mechanisms and fibrotic pathways in autoimmune and cholestatic liver diseases, using multi-omic platforms, sequencing technologies, spatial transcriptomics, and large language model neural networks. She receives funding from the Wellcome Trust, NIHR Academy of Medical Sciences, NIHR Biomedical Research Centre Oxford, and PSC Support. She is a passionate advocate for EASL, serving for many years on the Faculty for the EASL Congress, organising the Post-Graduate Course, EASL Basic Science and Clinical Schools, and contributing to Meet the Experts, Symposia, and EASL Deep Dive and Journal Club webcasts.